LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 19.69 | 84.90 | 1051 | 1239 | 0.8480 | 0.9165 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 19.69 | 84.90 | 1251 | 1239 | 1.0093 | 1.0048 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 19.69 | 84.90 | 1055 | 1239 | 0.8512 | 0.9184 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 19.69 | 84.90 | 1185 | 1239 | 0.9561 | 0.9769 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.40 | 84.90 | 1098 | 1454 | 0.7548 | 0.8674 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.40 | 84.90 | 1280 | 1454 | 0.8799 | 0.9386 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.40 | 84.90 | 1131 | 1454 | 0.7775 | 0.8809 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.40 | 84.90 | 1255 | 1454 | 0.8627 | 0.9292 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.10 | 84.90 | 1141 | 1616 | 0.7060 | 0.8427 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.10 | 84.90 | 1292 | 1616 | 0.7994 | 0.8974 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.10 | 84.90 | 1174 | 1616 | 0.7264 | 0.8551 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.10 | 84.90 | 1272 | 1616 | 0.7870 | 0.8904 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.81 | 84.90 | 1238 | 1769 | 0.6996 | 0.8434 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.81 | 84.90 | 1355 | 1769 | 0.7658 | 0.8818 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.81 | 84.90 | 1204 | 1769 | 0.6804 | 0.8317 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.81 | 84.90 | 1305 | 1769 | 0.7375 | 0.8657 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 26.51 | 84.90 | 1287 | 1923 | 0.6692 | 0.8293 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 26.51 | 84.90 | 1393 | 1923 | 0.7243 | 0.8617 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 26.51 | 84.90 | 1237 | 1923 | 0.6432 | 0.8133 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 26.51 | 84.90 | 1340 | 1923 | 0.6968 | 0.8458 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 28.21 | 84.90 | 1332 | 2091 | 0.6369 | 0.8140 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 28.21 | 84.90 | 1431 | 2091 | 0.6842 | 0.8424 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 28.21 | 84.90 | 1313 | 2091 | 0.6278 | 0.8084 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 28.21 | 84.90 | 1401 | 2091 | 0.6699 | 0.8339 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.92 | 84.90 | 1416 | 2237 | 0.6328 | 0.8152 | MN20160318_Q02 | L07 |